[1] 尹彦文,施开创,孙文超,等.2013-2019年广西边境地区低致病性禽流感病毒监测分析[J].中国畜牧兽医,2021,48(8):3002-3009. YIN Y W,SHI K C,SUN W C,et al.Surveillance analysis of low pathogenic Avian influenza virus in border areas of Guangxi from 2013 to 2019[J]. China Animal Husbandry & Veterinary Medicine,2021,48(8):3002-3009.(in Chinese) [2] TANG W,LI X,TANG L,et al.Characterization of the low-pathogenic H7N7 Avian influenza virus in Shanghai,China[J]. Poultry Science,2021,100(2):565-574. [3] 冯亚亚,郭晶,李玉保,等.禽流感DNA疫苗研究进展[J].中国畜牧兽医,2020,47(11):3667-3675. FENG Y Y,GUO J,LI Y B,et al.Review of DNA vaccine for avian influenza[J]. China Animal Husbandry & Veterinary Medicine,2020,47(11):3667-3675.(in Chinese) [4] BASHASHATI M,CHUNG D H,FALLAH MEHRABADI M H,et al.Evolution of H9N2 Avian influenza viruses in Iran,2017-2019[J]. Transboundary and Emerging Diseases,2021,68(6):3405-3414. [5] SWAYNE D E.Avian influenza vaccines and therapies for poultry[J]. Comparative Immunology, Microbiology and Infectious Diseases,2009,32(4):351-363. [6] 陈锦荣.流感H7N3减毒活疫苗有抗H7N9的潜力[J].微生物学免疫学进展,2014,42(6):69. CHEN J R.Live attenuated influenza H7N3 vaccine has the potential to resist H7N9[J]. Advances in Microbiology and Immunology,2014,42(6):69.(in Chinese) [7] 何丽霞.浅析禽流感疫苗的种类及应用[J].畜禽业,2022,33(9):27-29. HE L X.Analysis on the type and application of avian influenza vaccine[J]. Livestock and Poultry Industry,2022,33(9):27-29.(in Chinese) [8] LI Y T,LINSTER M,MENDENHA I H,et al.Avian influenza viruses in humans:Lessons from past outbreaks[J]. British Medical Bulletin,2019,132(1):81-95. [9] SINGHA S,SHAO K,ELLESTAD K K,et al.Nanoparticles for immune stimulation against infection,cancer,and autoimmunity[J]. ACS Nano,2018,12(11):10621-10635. [10] LUNG P,YANG J,LI Q.Nanoparticle formulated vaccines:Opportunities and challenges[J]. Nanoscale,2020,12(10):5746-5763. [11] HARMA S,JAISWAL S,DUFFY B,et al.Nanostructured materials for food applications:Spectroscopy,microscopy and physical properties[J]. Bioengineering,2019,6(2):26. [12] BABAPOOR S,NEEF T,MITTELHOLZER C,et al.A novel vaccine using nanoparticle platform to present immunogenic M2e against avian influenza infection[J]. Influenza Research and Treatment,2011,2011:126794. [13] ZELTINS A.Construction and characterization of virus-like particles:A review[J]. Molecular Biotechnology,2013,53(1):92-107. [14] LÓPEZ-SAGASETA J,MALITO E,RAPPUOLI R,et al.Self-assembling protein nanoparticles in the design of vaccines[J]. Computational and Structural Biotechnology Journal,2015,14:58-68. [15] ALEXIS F,PRIDGEN E,MOLNAR L K,et al.Factors affecting the clearance and biodistribution of polymeric nanoparticles[J]. Molecular Pharmaceutics,2008,5(4):505-515. [16] CHAUDHARY N,WEISSMAN D,WHITEHEAD K A.mRNA vaccines for infectious diseases:Principles,delivery and clinical translation[J]. Nature Reviews Drug Discovery,2021,20(11):817-838. [17] INOUE K,TAKANO H.Aggravating impact of nanoparticles on immune-mediated pulmonary inflammation[J]. Science World,2011,11:382-390. [18] LIAO C,LI Y,TJONG S C.Bactericidal and cytotoxic properties of silver nanoparticles[J]. International Journal of Molecular Sciences,2019,20(2):449. [19] TANG W,FAN W,LAU J,et al.Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics[J]. Chemical Society Reviews,2019,48(11):2967-3014. [20] PUSHKO P,TRETYAKOVA I.Influenza virus like particles (VLPs):Opportunities for H7N9 vaccine development[J]. Viruses,2020,12(5):518. [21] LIU Y V,MASSARE M J,PEARCE M B,et al.Recombinant virus-like particles elicit protective immunity against Avian influenza A (H7N9) virus infection in ferrets[J]. Vaccine,2015,33(18):2152-2158. [22] PRABAKARAN M,KUMAR S R,RAJ K V,et al.Cross-protective efficacy of Baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes[J]. Antiviral Research,2014,109:149-159. [23] HU C J,CHIEN C Y,LIU M T,et al.Multi-antigen Avian influenza A (H7N9) virus-like particles:Particulate characterizations and immunogenicity evaluation in murine and avian models[J]. BMC Biotechnology,2017,17(1):2. [24] LEE D H,PARK J K,LEE Y N,et al.H9N2 Avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals[J]. Vaccine,2011,29(23):4003-4007. [25] KANG H J,CHU K B,LEE D H,et al.Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs[J]. PLoS One,2019,14(6):e0216871. [26] GAMVRELLIS A,LEONG D,HANLEY J C,et al.Vaccines that facilitate antigen entry into dendritic cells[J]. Immunology and Cell Biology,2004,82(5):506-516. [27] GRGACIC E V,ANDERSON D A.Virus-like particles:Passport to immune recognition[J]. Methods,2006,40(1):60-65. [28] LEE L A,WANG Q.Adaptations of nanoscale viruses and other protein cages for medical applications[J]. Nanomedicine,2006,2(3):137-149. [29] 潘亮奇,李硕,吴梅花,等.禽流感纳米颗粒疫苗的研究进展[J].中国兽医科学,2020,50(12):1572-1579. PAN L Q,LI S,WU M H,et al.Research progress of avian influenza nanoparticle vaccin[J]. Chinese Veterinary Science,2020,50(12):1572-1579 . (in Chinese) [30] KANEKIYO M,WEI C J,YASSINE H M,et al.Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies[J]. Nature,2013,499(7456):102-106. [31] WANG Q,ZHANG Y,ZOU P,et al.Self-assembly M2e-based peptide nanovaccine confers broad protection against influenza viruses[J]. Frontiers in Microbiology,2020,11:1961. [32] LIM J,CHEONG Y,KIM Y S,et al.RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform[J]. Nanomedicine,2021,37:102438. [33] GONZALEZ-ARAMUNDIZ J V,CORDEIRO A S,CSABA N,et al.Nanovaccines:Nanocarriers for antigen delivery[J]. Biologie Aujourd’hui,2012,206(4):249-261. [34] WANG Y,DENG L,KANG S M,et al.Universal influenza vaccines:From viruses to nanoparticles[J]. Expert Review of Vaccines,2018,17(11):967-976. [35] BONIFÁCIO B V,SILVA P B,RAMOS M A,et al.Nanotechnology-based drug delivery systems and herbal medicines:A review[J]. International Journal of Nanomedicine,2014,9:1-15. [36] ZHAO K,RONG G,TENG Q,et al.Dendrigraft poly- L-lysines delivery of DNA vaccine effectively enhances the immunogenic responses against H9N2 Avian influenza virus infection in chickens[J]. Nanomedicine,2020,27:102209. [37] CHOWDHURY M Y E,KIM T H,UDDIN M B,et al.Mucosal vaccination of conserved sM2,HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes[J]. Veterinary Microbiology,2017,201:240-251. [38] WANG Y,DENG L,KANG S M,et al.Universal influenza vaccines:From viruses to nanoparticles[J]. Expert Review of Vaccines,2018,17(11):967-976. [39] 毕毓彤,周萌萌,李承禹,等.聚合物纳米材料在疫苗佐剂领域的应用进展[J].现代畜牧兽医,2021,4:78-83. BI Y T,ZHOU M M,LI C Y,et al.Application progress of polymer nanomaterials in the field of vaccine adjuvants[J]. Modern Animal Husbandry and Veterinary Medicine,2021,4:78-83.(in Chinese) [40] BALDERRAMA-GONZÁLEZ A S,PIÑÓN-CASTILLO H A,RAMÍREZ-VALDESPINO C A,et al.Antimicrobial resistance and inorganic nanoparticles[J]. International Journal of Molecular Sciences,2021,22(23):12890. [41] SAYHI M,OUERGHI O,BELGACEM K,et al.Electrochemical detection of Influenza virus H9N2 based on both immunomagnetic extraction and gold catalysis using an immobilization-free screen printed carbon microelectrode[J]. Biosensors & Bioelectronics,2018,107:170-177. [42] RICHARDS S J,BAKER A N,WALKER M,et al.Polymer-stabilized sialylated nanoparticles:Synthesis,optimization,and differential binding to influenza hemagglutinins[J].Biomacromolecules,2020,21(4):1604-1612. [43] 王一冰,邝智祥,叶金玲,等.纳米铜、灵芝孢子粉与大豆异黄酮对1~30日龄清远麻鸡生长、免疫及抗氧化性能的影响[J].中国畜牧兽医,2021,48(7):2415-2423. WANG Y B,KUANG Z X,YE J L,et al.Effects of nano copper,spores of Ganoderma iucidum and soybean isoflavone on performance of growth,immune and antioxidation of Qingyuan partridge chickens from 1 to 30 days[J]. China Animal Husbandry & Veterinary Medicine,2021,48(7):2415-2423.(in Chinese) [44] PREL A,LE GALL-RECULE G,JESTIN V.Achievement of Avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic Avian influenza strains in duck[J]. Avian Pathology, 2008, 37(5):513-520. [45] SMITH T,O’KENNEDY M M,WANDRAG D B R,et al.Efficacy of a plant-produced virus-like particle vaccine in chickens challenged with Influenza A H6N2 virus[J]. Plant Biotechnology Journal,2020,18(2):502-512. [46] PRABAKARAN M,KUMAR S R,RAJ K V,et al.Cross-protective efficacy of Baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes[J]. Antiviral Research,2014,109:149-159. [47] HU C J,CHIEN C Y,LIU M T,et al.Multi-antigen Avian influenza A (H7N9) virus-like particles:Particulate characterizations and immunogenicity evaluation in murine and avian models[J]. BMC Biotechnology,2017,17(1):2. [48] QI M,ZHANG X E,SUN X,et al.Intranasal nanovaccine confers homo- and hetero- subtypic influenza protection[J]. Small, 2018,14(13):e1703207. [49] KARCH C P,LI J,KULANGARA C,et al. Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge[J]. Nanomedicine, 2017,13(1):241-251. [50] LIN S Y,YAO B Y,HU C J,et al.Induction of robust immune responses by CpG-ODN-Loaded hollow polymeric nanoparticles for antiviral and vaccine applications in chickens[J]. International Journal of Nanomedicine,2020,15:3303-3318. [51] SINGH S M,ALKIE T N,ABDELAZIZ K T,et al.Characterization of immune responses to an inactivated Avian influenza virus vaccine adjuvanted with nanoparticles containing CpG ODN[J]. Viral Immunology,2016,29(5):269-275. [52] JAZAYERI S D,IDERIS A,ZAKARIA Z,et al.Cytotoxicity and immunological responses following oral vaccination of nanoencapsulated Avian influenza virus H5 DNA vaccine with green synthesis silver nanoparticles[J]. Control Release,2012,161(1):116-123. [53] XIAO G Y,CHEN B B,HE M,et al.Determination of avian influenza A (H9N2) virions by inductively coupled plasma mass spectrometry based magnetic immunoassay with gold nanoparticles labeling[J]. Spectrochimica Acta Part B:Atomic Spectroscopy,2017,138:90-96. [54] SANCHEZ-GUZMAN D,LE G P,VILLERET B,et al.Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity[J]. Biomaterials,2019,217:119308. [55] 刘宝玲,李春玲,蒋智勇,等.纳米银对猪链球菌体外抗菌活性及其生物膜形成的影响[J].中国畜牧兽医,2022,49(3):1172-1180. LIU B L,LI C L,JIANG Z Y,et al.Effects of silver nanparticles on the activity of Streptococcus suis and its biofilm formation in vitro[J]. China Animal Husbandry & Veterinary Medicine,2022,49(3):1172-1180.(in Chinese) [56] WANG Y,XIE Y,LUO J,et al.Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel Coronavirus[J]. Nano Today,2021,38:101139. [57] BOUVIER N M.The future of influenza vaccines:A historical and clinical perspective[J]. Vaccines,2018,6(3):58. [58] PUZELLI S,TRANI L,FABIANI C,et al.Serological analysis of serum samples from humans exposed to Avian H7 influenza viruses in Italy between 1999 and 2003[J]. Journal of Infectious Diseases,2005,192(8):1318-1322. |